Stay updated on Ixekizumab Delivery in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.

Latest updates to the Ixekizumab Delivery in Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has undergone significant content removal regarding the study of ixekizumab for plaque psoriasis, including detailed inclusion and exclusion criteria, while a new identifier and version revision have been added.SummaryDifference9%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check103 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to Ixekizumab Delivery in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.